🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the long-term safety of pomaglumet...
Status
Terminated
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2011-12
Trial ID
NCT01487083
Treatments Being Tested
An inpatient/outpatient study to see if LY2140023 is better than placebo in...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2010-03
Trial ID
NCT01086748
Treatments Being Tested
This is the first study of pomaglumetad in humans using methamphetamine. Th...
Status
Terminated
Location
UCLA
Start Date
2017-08-01
Trial ID
NCT03106571
Treatments Being Tested
This study is designed to compare 3 doses of LY2140023 for the treatment of...
Status
Terminated
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2010-05
Trial ID
NCT01125358
The study will evaluate the effect of different particle size of LY2140023....
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2012-04
Trial ID
NCT01591330
Treatments Being Tested
Participants will be administered several doses of pomaglumetad (POMA) (low...
Status
Completed
Location
New York State Psychiatric Institute
Start Date
2018-04-17
Trial ID
NCT03321617
Treatments Being Tested
In this study, we propose to employ a randomized, double-blind, placebo-con...
Status
Terminated
Location
Multiple Locations
Start Date
2014-09
Trial ID
NCT02234687
Treatments Being Tested
This study is designed to explore the effect of increased and decreased uri...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559), Mon - Fri, from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician.
Start Date
2011-09
Trial ID
NCT01440478
Treatments Being Tested
The purpose of this study is to determine whether at least 1 dose level of ...
Status
Terminated
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2011-03
Trial ID
NCT01307800
The purpose of this study is to determine whether or not people with schizo...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2011-11
Trial ID
NCT01452919